SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000930413-23-000387
Filing Date
2023-02-14
Accepted
2023-02-14 08:50:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 c105525_sc13ga.htm SC 13G/A 78335
  Complete submission text file 0000930413-23-000387.txt   80026
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82025 | Film No.: 23623035
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NUVEEN INVESTMENTS 333 W. WACKER DRIVE CHICAGO IL 60606
Business Address C/O NUVEEN INVESTMENTS 333 W. WACKER DRIVE CHICAGO IL 60606 (312) 917-7700
Nuveen Asset Management, LLC (Filed by) CIK: 0001521019 (see all company filings)

IRS No.: 274357327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A